Only 11.2% of participants stopped the trial due to side effects, and the discontinuation rate dropped significantly after week 24, suggesting those who make it through the early phase generally tolerate it well long-term
Decades of research to discover treatments for AD have been largely unsuccessful as well as extremely expensive
To get closer to cause-and-effect answers, researchers conducted a target-trial emulation in 2025
At each Accutane visit, bloodwork will be performed to assess liver enzyme levels and liver function
Feel better every day with targeted wellness & longevity treatments in White Plains, NY At our White Plains clinic, we offer vitamin IV drips, NAD+, peptides, glutathione, lipotropic injections, and more